Elucidation of the Molecular Mechanism of Cardiac Response to the Ischemia Reperfusion Stresses and Establishment of Treatment Based on the Molecular Mechanism
阐明心脏对缺血再灌注应激反应的分子机制并建立基于分子机制的治疗方法
基本信息
- 批准号:09470162
- 负责人:
- 金额:$ 9.6万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. Molecular mechanism of cardiac response to hypoxia/reoxygenation : We showed that hypoxia/reoxygenation activated Src family tyrosine kinases, p21^<ras>, three MAPK family member kinases and their upstream as well as downstream kinases, Jak/STAT tyrosine kinases, and a transcription factor ATF-2. The signal transduction cascades activated by these stimuli were at least partly different. 2. Autocrine mechanism via certain humoral factors involved in the activation of intracellular signaling induced by hypoxia/reoxygenation : (A)We showed that the activation of intracellular signaling in cardiac myocytes induced by hypoxia was mediated by VEGF in an autocrine fashion. This autocrine mechanism seemed to play a protective role in cardiac response to hypoxic stresses by suppressing apoptotic process and increasing adhesion between cardiac myocytes and extracellular matrix. (B)We found that similar autocrine mechanism was involved in the activation of intracellular signaling in cardiac my … More ocytes induced by reoxygenation, and we are now isolating and purifying the humoral factor. 3. Molecular mechanism of cardiac response to relative hypoxia : We showed that the activation of intracellular signaling in cardiac myocytes induced by pulsatile mechanical stretch (relative hypoxia) was also mediated by VEGF in an autocrine fashion. 4. Serum levels of the humoral factor, which mediates cardiac response to ischemia/reperfusion(hypoxia/reoxygenation) : (A)By meas uring the serum levels of VEGF in patients with acute myocardial infarction undergoing early reperfusion therapy, we demonstrated that VEGF could be a sensitive indicator of ischemic (hypoxic) state. This also strongly supported the data of 2. (A). (B)We are now isolating and purifying the humoral factor involved in the activation of intracellular signaling induced by reoxygenation, and we suppose that the serum levels of the humaral factor will be a good indicator of reperfused (reoxygenated) state in the heart of these patients. Less
1. 心脏对缺氧/再氧化反应的分子机制:我们发现缺氧/再氧化激活了Src家族酪氨酸激酶,p21^<ras>,三个MAPK家族成员激酶及其上游和下游激酶,Jak/STAT酪氨酸激酶和转录因子ATF-2。这些刺激激活的信号转导级联至少部分不同。2. 通过某些体液因子参与缺氧/再氧化诱导的细胞内信号激活的自分泌机制:(A)我们发现缺氧诱导的心肌细胞内信号激活是由VEGF以自分泌方式介导的。这种自分泌机制似乎通过抑制凋亡过程和增加心肌细胞与细胞外基质之间的粘附,在心脏对缺氧应激的反应中发挥保护作用。(B)我们发现类似的自分泌机制参与了心肌细胞内信号的激活,更多的细胞被再氧化诱导,我们现在正在分离和纯化体液因子。3. 心脏对相对缺氧反应的分子机制:我们发现搏动性机械拉伸(相对缺氧)诱导的心肌细胞内信号的激活也由VEGF以自分泌方式介导。4. 介导心脏缺血/再灌注(缺氧/再氧)反应的体液因子的血清水平:(A)通过测量急性心肌梗死患者早期再灌注治疗的血清VEGF水平,我们证明VEGF可能是缺血(缺氧)状态的敏感指标。这也有力地支持了2。(A) (B)我们现在正在分离和纯化参与再氧化诱导的细胞内信号激活的体液因子,我们认为血清中体液因子的水平将是这些患者心脏再灌注(再氧化)状态的良好指标。少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Seko Y, et al: "Expression of costimulatory molecules B7-1,B7-2,and CD40 in the heart of patients with acute myocarditis and -----------" Circulation. 97. 637-639 (1998)
Seko Y 等人:“急性心肌炎患者心脏中共刺激分子 B7-1、B7-2 和 CD40 的表达以及循环。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Seko Y,Takahashi N,Tobe K,Kadowaki T,Yazaki Y: "Vascular endothelial growth factor (VEGF) activates mitogen-activated protein (MAP) kinase, S6 kinase (p90^<rsk>) , and Raf-1 in cultured rat cardiac myocytes" J Cell Physiol. 175. 239-246 (1998)
Seko Y、Takahashi N、Tobe K、Kadowaki T、Yazaki Y:“血管内皮生长因子 (VEGF) 激活培养大鼠中的丝裂原激活蛋白 (MAP) 激酶、S6 激酶 (p90^<rsk>) 和 Raf-1
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Seko Y, et al.: "Pulsatile Stretch stimulates vascular endothelial…" Biochem Biophys Res Commun. 254. 462-465 (1999)
Seko Y 等人:“脉动拉伸刺激血管内皮……”Biochem Biophys Res Commun。254. 462-465 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Seko Y, et al.: "Effects of in vivo administration of anti B7-1/B7-2 monoclonal antibodies on murine acute myocarditis--------" Circ Res. (in press).
Seko Y 等人:“体内施用抗 B7-1/B7-2 单克隆抗体对小鼠急性心肌炎的影响--------”Circ Res。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Seko Y,et al.: "Vascular endothelial growth factor(VEGF)activates…" J Cell Physiol. 175. 239-246 (1998)
Seko Y 等人:“血管内皮生长因子 (VEGF) 激活……”J Cell Physiol。175. 239-246 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SEKO Yoshinori其他文献
SEKO Yoshinori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SEKO Yoshinori', 18)}}的其他基金
Identification of the Receptor for ORAIP That Mediates Cardiac Response to Oxidative Stresses and Development of Treatment
介导心脏对氧化应激反应的 ORAIP 受体的鉴定和治疗方法的开发
- 批准号:
15390240 - 财政年份:2003
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification of the ligands for Cardiac Orphan G protein -Coupled Receptors and Development of T herapy Modulating Cardiac Function
心脏孤儿 G 蛋白偶联受体配体的鉴定及心脏功能调节疗法的开发
- 批准号:
13470140 - 财政年份:2001
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Purification and Identification of the Bioactive Subs tance That Mediates Cardiac Response to the Ischemia Reperfusion Stresses and Development of Treatment
介导心脏对缺血再灌注应激反应的生物活性物质的纯化和鉴定以及治疗方法的开发
- 批准号:
11470158 - 财政年份:1999
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Development of the Specific Immunotherapy for Myocarditis, Dilated Cardiomyopathy(Chronic Myocarditis), and Takayasu Arteritis.
心肌炎、扩张型心肌病(慢性心肌炎)、大动脉炎的特异性免疫疗法的开发。
- 批准号:
11557048 - 财政年份:1999
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Development of Molecular Biologic Diagnostic and Therapeutic Method of Asymptomatic Myocardial Ischemia and Unstable Angina
无症状心肌缺血及不稳定型心绞痛分子生物学诊断及治疗方法的进展
- 批准号:
07557231 - 财政年份:1995
- 资助金额:
$ 9.6万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
相似国自然基金
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
- 批准号:82370751
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
- 批准号:82371301
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
TRIM21蛋白促进HIF1α的降解介导耳蜗血管纹缘细胞缺血再灌注致听力损伤的机制研究
- 批准号:82371142
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
- 批准号:81070041
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Development ofsynthetic heparin to protect liver graft from ischemia reperfusion injury duringtransplantation
开发合成肝素以保护移植肝免受移植过程中的缺血再灌注损伤
- 批准号:
10759102 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Glomerular and Tubular Function in the Recovering Kidney
肾脏恢复中的肾小球和肾小管功能
- 批准号:
10587898 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Roles of Endothelial and Smooth Muscle KATP Channels in Myocardial Ischemic Injury
内皮和平滑肌 KATP 通道在心肌缺血性损伤中的作用
- 批准号:
10839729 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Defining the Spatiotemporal Underpinnings of Neutrophil Recruitment, Microvascular Flow, and Oxygenation in Ischemic Stroke
定义缺血性中风中中性粒细胞募集、微血管血流和氧合的时空基础
- 批准号:
10449713 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Ferroptosis in knock-in sepiapterin reductase mutation rabbits
敲入墨蝶呤还原酶突变兔的铁死亡
- 批准号:
10747716 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Ex vivo maintenance of endothelial cell barrier integrity via gap junction modification to prevent early ischemic injury in solid organ transplantation
通过间隙连接修饰离体维持内皮细胞屏障完整性以预防实体器官移植中的早期缺血性损伤
- 批准号:
10741452 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
The Role of Neutrophils in Ischemia/Reperfusion Injury following Acute Stroke
中性粒细胞在急性中风后缺血/再灌注损伤中的作用
- 批准号:
10606952 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:
Dissecting the Molecular Link Between Stroke, Actin, and Alzheimer's Disease
剖析中风、肌动蛋白和阿尔茨海默病之间的分子联系
- 批准号:
10772704 - 财政年份:2023
- 资助金额:
$ 9.6万 - 项目类别:














{{item.name}}会员




